Anaemia - A diabetologist's dilemma?

Acta Diabetologica

Volumn 39, Issue SUPPL. 1, 2002, Pages

  Bilous, R ^a  

^a JAMES COOK UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

Anaemia; Diabetes; Erythropoietin resistance; Renal disease; Tubulointerstitial damage

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ERYTHROPOIETIN; HEMOGLOBIN; CREATININE;

ANEMIA; AUTONOMIC NEUROPATHY; CELL DAMAGE; CONFERENCE PAPER; DIABETES MELLITUS; DIABETIC NEPHROPATHY; ERYTHROCYTE; ERYTHROPOIESIS; HEMOGLOBIN DETERMINATION; HUMAN; HYPOXIA; INSULIN DEPENDENT DIABETES MELLITUS; INTERSTITIAL NEPHRITIS; KIDNEY FAILURE; KIDNEY FUNCTION; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT CARE; PRACTICE GUIDELINE; PRIORITY JOURNAL; RISK FACTOR; CHRONIC KIDNEY FAILURE; METABOLISM; PATHOLOGY; PHYSIOLOGY; REVIEW;

ANEMIA; CREATININE; DIABETES MELLITUS, INSULIN-DEPENDENT; DIABETIC NEPHROPATHIES; ERYTHROPOIETIN; HEMOGLOBINS; HUMAN; KIDNEY FAILURE, CHRONIC; DIABETES MELLITUS, TYPE 1; HUMANS;

EID: 0036095740     PISSN: 09405429     EISSN: None     Source Type: Journal    
DOI: 10.1007/s005920200004     Document Type: Conference Paper

References (17)

1. Anemia with erythropoietin deficiency occurs early in diabetic nephropathy
2. Diabetes mellitus increases the severity of anemia in non-dialyzed patients with renal failure
3. Anemia: An early complication of chronic renal insufficiency
4. Reduced erythropoietin responsiveness to anemia in diabetic patients before advanced diabetic nephropathy
5. Type 2 diabetic patients with nephropathy show structural-functional relationships that are similar to type 1 disease
6. Anemia due to reduced serum erythropoietin concentration in non-uremic diabetic patients
7. Erythropoietin responsive anaemia in diabetics neuropathy with and without nephropathy
8. Erythropoietin depletion and anaemia in diabetes mellitus
9. The anemia of primary autonomic failure and its reversal with recombinant erythropoietin
10. Anemia secondary to low erythropoietin in a patient with normal renal function
11. Erythropoietin response to hypoxia in patients with diabetic autonomic neuropathy and non-diabetic chronic renal failure
12. European best practice guidelines for the management of anaemia in patients with chronic renal failure
13. Should anaemia in different subtypes of CRF patients be managed differently?
14. Reversal of anaemia by erythropoietin therapy retards the progression of chronic renal failure, especially in non-diabetic patients
15. Beneficial influence of recombinant human erythropoietin therapy on the rate of progression of chronic renal failure in predialysis patients
16. Use of erythropoietin before initiation of dialysis and its impact on mortality
17. Strict volume control normalizes hypertension in peritoneal dialysis patients